Skip to main content
. 2016 Jan 26;5(1):e002503. doi: 10.1161/JAHA.115.002503

Table 1.

Baseline Characteristics of Cardiovascular Health Study Participants by Consumption of Caffeinated Products

<1 Serving Per Day (n=548) ≥1 Servings Per Day (n=840) P Value
Demographics
Mean age±SD, y 72.2±5.1 71.7±4.8 0.08
Male, n (%) 274 (50.0) 371 (44.2) 0.03
Race, n (%) 0.21
White 517 (94.3) 800 (95.2)
Black 29 (5.3) 34 (4.1)
Other 2 (0.4) 6 (0.71)
Income, n (%) 0.90
<$12 000 103 (20.0) 161 (20.0)
$12 000 to $34 999 278 (53.9) 442 (54.9)
≥$35 000 135 (26.2) 202 (25.1)
Education, n (%) 0.49
High school or less 300 (54.8) 448 (53.3)
Vocational school 50 (9.1) 76 (9.1)
Some college 74 (13.5) 143 (17.0)
4 years of college 62 (11.3) 91 (10.8)
Postgraduate 61 (11.2) 82 (9.8)
Mean BMI+SD, kg/m2 26.8±4.2 26.6±4.2 0.36
Habits
Mean caloric intake ±SD, kcal 1771.0±636.5 1885.8±676.6 >0.99
Smoking status, n (%) 0.12
Never smoker 262 (47.8) 367 (43.7)
Past smoker 245 (44.7) 385 (45.9)
Current smoker 41 (7.5) 87 (10.4)
Median number of alcoholic drinks per week (IQR) 0 (0–1) 0 (0–2) <0.01
Medical history
Diabetes mellitus, n (%) 82 (15.0) 129 (15.4) 0.83
Hypertension, n (%) 304 (55.5) 456 (54.4) 0.70
Coronary artery disease, n (%) 118 (21.5) 161 (19.2) 0.28
Atrial fibrillation, n (%) 6 (1.1) 13 (1.6) 0.50
Congestive heart failure, n (%) 18 (3.3) 25 (3.0) 0.75
Medications
β‐Blocker, n (%) 80 (14.6) 115 (13.7) 0.63
Calcium channel blocker, n (%) 55 (10.1) 95 (11.3) 0.46
Digoxin, n (%) 39 (7.1) 50 (6.0) 0.38
Class I antiarrhythmic, n (%) 22 (4.0) 27 (3.2) 0.43
Class III antiarrhythmic, n (%) 0 (0.0) 2 (0.2) 0.25

Values are reported as mean±SD, median (IQR), or number (percentage). BMI indicates body mass index; IQR, interquartile range.